Stocks Hitting 52-Week Highs

shares touched a new 52-week high of $1.84 after the company reported strong Q4 earnings.

shares climbed 14.31% to reach a new 52-week high of $15.82 after the company agreed to be acquired by

for $15.85 per share.

shares rose 3.29% to reach a new 52-week high of $28.22 after the company reported that it has received a FDA Fast Track Designation for ACTIMMUNE to treat Friedreich's Ataxia.

shares touched a new 52-week high of $6.25. Eldorado Resorts' trailing-twelve-month revenue is $361.82 million.